UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Patterned Aluminum/Polydimethylsiloxane-Laminated Film for a Solvent-Driven Soft Actuator with Programmable and Multistable Shape Morphing

ACS applied materials & interfaces, 2022-11, Vol.14 (43), p.49171-49180

2022

Volltextzugriff (PDF)

Characterization and Mechanism Elucidation of Dye Adsorption Using Cuprous Selenide Nanoparticles from Aqueous Solutions

Chemical research in Chinese universities, 2016-12, Vol.32 (6), p.1010-1015

2016

Volltextzugriff (PDF)

A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1

Genome Biology, 2018-12, Vol.19 (1), p.218-218, Article 218

2018

Volltextzugriff (PDF)

Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration

Molecular cell, 2010-07, Vol.39 (1), p.133-144

2010

Volltextzugriff (PDF)

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial

The lancet oncology, 2022-02, Vol.23 (2), p.220-233

2022

Volltextzugriff (PDF)

Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in HCC Cells through the Mitophagy Pathway

Molecular therapy. Nucleic acids, 2021-03, Vol.23, p.264-276

2021

Volltextzugriff (PDF)

Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation

The Journal of experimental medicine, 2020-05, Vol.217 (5)

2020

Volltextzugriff (PDF)

Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1512-1522

2021

Volltextzugriff (PDF)

Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.7762-7771

2023

Volltextzugriff (PDF)

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-09, Vol.328 (12), p.1223

2022

Volltextzugriff (PDF)

Anti-tumor and immunomodulating activities of a polysaccharide from the root of Sanguisorba officinalis L

International journal of biological macromolecules, 2012-11, Vol.51 (4), p.484-488

2012

Volltextzugriff (PDF)

Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network

Genome Biology, 2021-08, Vol.22 (1), p.233-29, Article 233

2021

Volltextzugriff (PDF)

Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A

Scientific reports, 2017-10, Vol.7 (1), p.13686-9, Article 13686

2017

Volltextzugriff (PDF)

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

BMC cancer, 2021-01, Vol.21 (1), p.56-56, Article 56

2021

Volltextzugriff (PDF)

A Phase 2 Study of Tislelizumab in Combination With Platinum-Based Chemotherapy as First-line Treatment for Advanced Lung Cancer in Chinese Patients

Lung cancer (Amsterdam, Netherlands), 2020-09, Vol.147, p.259-268

2020

Volltextzugriff (PDF)

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

Journal of clinical oncology, 2023-01, Vol.41 (3), p.651-663

2023

Volltextzugriff (PDF)

Interface interaction of MoS2 nanosheets with DNA based aptameric biosensor for carbohydrate antigen 15–3 detection

Microchemical journal, 2020-06, Vol.155, p.104675, Article 104675

2020

Volltextzugriff (PDF)

Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT/ERK1/2/STAT3-SOX2/Snail signaling pathway

Life sciences (1973), 2020-10, Vol.258, p.118158-118158, Article 118158

2020

Volltextzugriff (PDF)

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003214

2021

Volltextzugriff (PDF)

Clonal evolution characteristics and reduced dimension prognostic model for non-metastatic metachronous bilateral breast cancer

Frontiers in oncology, 2022-09, Vol.12, p.963884-963884

2022

Volltextzugriff (PDF)

Author Correction: Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network

Genome Biology, 2021-09, Vol.22 (1), p.1-272, Article 272

2021

Volltextzugriff (PDF)

The correlation between immune status of patients and their prognosis in non-small cell lung cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e23192-e23192

2017

Volltextzugriff (PDF)

TORCHLIGHT: A randomized, double-blind, phase III trial of toripalimab versus placebo, in combination with nab-paclitaxel(nab-P) for patients with metastatic or recurrent triple-negative breast cancer (TNBC)

Journal of clinical oncology, 2023-06, Vol.41 (17_suppl), p.LBA1013-LBA1013

2023

Volltextzugriff (PDF)

Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study

Clinical cancer research, 2021-01, Vol.27 (1), p.70-77

2021

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(82)

Sprache

Englisch
(82)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Patterned Aluminum/Polydimethylsiloxane-Laminated Film for a Solvent-Driven Soft Actuator with Programmable and Multistable Shape Morphing

Characterization and Mechanism Elucidation of Dye Adsorption Using Cuprous Selenide Nanoparticles from Aqueous Solutions

A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1

Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial

Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in HCC Cells through the Mitophagy Pathway

Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation

Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial

Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

Anti-tumor and immunomodulating activities of a polysaccharide from the root of Sanguisorba officinalis L

Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network

Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

A Phase 2 Study of Tislelizumab in Combination With Platinum-Based Chemotherapy as First-line Treatment for Advanced Lung Cancer in Chinese Patients

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

Interface interaction of MoS2 nanosheets with DNA based aptameric biosensor for carbohydrate antigen 15–3 detection

Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT/ERK1/2/STAT3-SOX2/Snail signaling pathway

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Clonal evolution characteristics and reduced dimension prognostic model for non-metastatic metachronous bilateral breast cancer

Author Correction: Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network

The correlation between immune status of patients and their prognosis in non-small cell lung cancer

TORCHLIGHT: A randomized, double-blind, phase III trial of toripalimab versus placebo, in combination with nab-paclitaxel(nab-P) for patients with metastatic or recurrent triple-negative breast cancer (TNBC)

Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study

Suchergebnisse filtern